| First choice | In patients undergoing AF ablation, the OAC of choice is uninterrupted warfarin |
| Second choice | Uninterrupted dabigatran, apixaban, or rivaroxaban. |
| Third choice | Interrupted warfarin with bridging |
| Comment | Data on the efficacy and safety of edoxaban in patients undergoing AF ablation are not available |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.